These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
279 related articles for article (PubMed ID: 8816502)
21. Apoptotic and growth-promoting activity of E2F modulated by MDM2. Loughran O; La Thangue NB Mol Cell Biol; 2000 Mar; 20(6):2186-97. PubMed ID: 10688665 [TBL] [Abstract][Full Text] [Related]
22. Expression of dominant-negative mutant DP-1 blocks cell cycle progression in G1. Wu CL; Classon M; Dyson N; Harlow E Mol Cell Biol; 1996 Jul; 16(7):3698-706. PubMed ID: 8668186 [TBL] [Abstract][Full Text] [Related]
23. DP-2, a heterodimeric partner of E2F: identification and characterization of DP-2 proteins expressed in vivo. Rogers KT; Higgins PD; Milla MM; Phillips RS; Horowitz JM Proc Natl Acad Sci U S A; 1996 Jul; 93(15):7594-9. PubMed ID: 8755520 [TBL] [Abstract][Full Text] [Related]
24. Interaction of the 72-kilodalton human cytomegalovirus IE1 gene product with E2F1 coincides with E2F-dependent activation of dihydrofolate reductase transcription. Margolis MJ; Pajovic S; Wong EL; Wade M; Jupp R; Nelson JA; Azizkhan JC J Virol; 1995 Dec; 69(12):7759-67. PubMed ID: 7494286 [TBL] [Abstract][Full Text] [Related]
25. Reduction of total E2F/DP activity induces senescence-like cell cycle arrest in cancer cells lacking functional pRB and p53. Maehara K; Yamakoshi K; Ohtani N; Kubo Y; Takahashi A; Arase S; Jones N; Hara E J Cell Biol; 2005 Feb; 168(4):553-60. PubMed ID: 15716376 [TBL] [Abstract][Full Text] [Related]
26. Blocking the transcription factor E2F/DP by dominant-negative mutants in a normal breast epithelial cell line efficiently inhibits apoptosis and induces tumor growth in SCID mice. Bargou RC; Wagener C; Bommert K; Arnold W; Daniel PT; Mapara MY; Grinstein E; Royer HD; Dörken B J Exp Med; 1996 Mar; 183(3):1205-13. PubMed ID: 8642262 [TBL] [Abstract][Full Text] [Related]
27. Heterodimerization of the transcription factors E2F-1 and DP-1 is required for binding to the adenovirus E4 (ORF6/7) protein. Helin K; Harlow E J Virol; 1994 Aug; 68(8):5027-35. PubMed ID: 8035503 [TBL] [Abstract][Full Text] [Related]
28. Interaction between cell cycle regulator, E2F-1, and NF-kappaB mediates repression of HIV-1 gene transcription. Kundu M; Guermah M; Roeder RG; Amini S; Khalili K J Biol Chem; 1997 Nov; 272(47):29468-74. PubMed ID: 9368006 [TBL] [Abstract][Full Text] [Related]
29. In vivo association of E2F and DP family proteins. Wu CL; Zukerberg LR; Ngwu C; Harlow E; Lees JA Mol Cell Biol; 1995 May; 15(5):2536-46. PubMed ID: 7739537 [TBL] [Abstract][Full Text] [Related]
30. E2F-4 switches from p130 to p107 and pRB in response to cell cycle reentry. Moberg K; Starz MA; Lees JA Mol Cell Biol; 1996 Apr; 16(4):1436-49. PubMed ID: 8657117 [TBL] [Abstract][Full Text] [Related]
31. Inhibition of E2F-mediated transcription by p202. Choubey D; Li SJ; Datta B; Gutterman JU; Lengyel P EMBO J; 1996 Oct; 15(20):5668-78. PubMed ID: 8896460 [TBL] [Abstract][Full Text] [Related]
32. The subcellular localization of E2F-4 is cell-cycle dependent. Lindeman GJ; Gaubatz S; Livingston DM; Ginsberg D Proc Natl Acad Sci U S A; 1997 May; 94(10):5095-100. PubMed ID: 9144196 [TBL] [Abstract][Full Text] [Related]
33. E2F-1-induced p53-independent apoptosis in transgenic mice. Holmberg C; Helin K; Sehested M; Karlström O Oncogene; 1998 Jul; 17(2):143-55. PubMed ID: 9674698 [TBL] [Abstract][Full Text] [Related]
34. Deregulated expression of E2F family members induces S-phase entry and overcomes p16INK4A-mediated growth suppression. Lukas J; Petersen BO; Holm K; Bartek J; Helin K Mol Cell Biol; 1996 Mar; 16(3):1047-57. PubMed ID: 8622649 [TBL] [Abstract][Full Text] [Related]
35. Transcription factor E2F-1 is upregulated in response to DNA damage in a manner analogous to that of p53. Blattner C; Sparks A; Lane D Mol Cell Biol; 1999 May; 19(5):3704-13. PubMed ID: 10207094 [TBL] [Abstract][Full Text] [Related]
36. Topoisomerase IIalpha mediates E2F-1-induced chemosensitivity and is a target for p53-mediated transcriptional repression. Nip J; Hiebert SW Cell Biochem Biophys; 2000; 33(2):199-207. PubMed ID: 11325040 [TBL] [Abstract][Full Text] [Related]
37. Regulation of E2F through ubiquitin-proteasome-dependent degradation: stabilization by the pRB tumor suppressor protein. Campanero MR; Flemington EK Proc Natl Acad Sci U S A; 1997 Mar; 94(6):2221-6. PubMed ID: 9122175 [TBL] [Abstract][Full Text] [Related]
38. TRIP-Br: a novel family of PHD zinc finger- and bromodomain-interacting proteins that regulate the transcriptional activity of E2F-1/DP-1. Hsu SI; Yang CM; Sim KG; Hentschel DM; O'Leary E; Bonventre JV EMBO J; 2001 May; 20(9):2273-85. PubMed ID: 11331592 [TBL] [Abstract][Full Text] [Related]
39. Distinct mechanisms of nuclear accumulation regulate the functional consequence of E2F transcription factors. Allen KE; de la Luna S; Kerkhoven RM; Bernards R; La Thangue NB J Cell Sci; 1997 Nov; 110 ( Pt 22)():2819-31. PubMed ID: 9427290 [TBL] [Abstract][Full Text] [Related]
40. Molecular and functional characterisation of E2F-5, a new member of the E2F family. Buck V; Allen KE; Sørensen T; Bybee A; Hijmans EM; Voorhoeve PM; Bernards R; La Thangue NB Oncogene; 1995 Jul; 11(1):31-8. PubMed ID: 7542760 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]